Add some news
News Page for: Advanced Medicine Solutions, AMS (graph)
|
Add some news |
Select Article: |
|
|
Item
|
Date
|
Source & Article
|
|
15th July
|
FT: Director Sells: 150K shares, £18K, 1 director. | |
|
5th July
|
5/7/00 08:00 BST Advanced Medical Solutions, Novartis in Swiss dressing distribution deal LONDON (AFX) - Advanced Medical Solutions Group PLC said it has signed an agreement with Novartis Consumer Health, Europe, for the distribution of its ActivHealT range of innovative wound dressings into Switzerland. Novartis Consumer Health will begin distribution of the advanced woundcare products under the MerfenR Actiplast brand in late summer 2000, it added. rn . | |
|
25th Aug 2000
|
newssource: RNS - 25/08 @ 11:12 news: Advanced Medical Solutions Group plc will announce its Interim results for the year ended 30 June 2000 on Wednesday 6 September 2000 | |
|
6 Sep 2000
|
Web Site news: AMS are making significant progress. Share price up today against the markets (especially Techmark). For full copy of report download from AMS website or email Richard and he will forward on. 6 September 2000. Advanced Medical Solutions Group plc., today announced interim results for the six months ended 30 June 2000. Highlights Turnover up 28% to £3.6 million Losses reduced by 44% to £1.8 million (£3.13m loss) Operating cash out-flow reduced by 76% to £0.7 million Marketing and distribution deals signed with Novartis Consumer Health for Germany and Switzerland . |
|
|
23 Dec 2000
|
FT: Directors Buys: 150K shares costing £18K between 2 of em. | |
|
7 Dec 2000
|
Advanced Medical Solutions, AGS in sole distribution agreement LONDON (AFX) - Advanced Medical Solutions Group PLC said it has signed an agreement with AGS Laboratories Inc of Texas where AGS has taken over sole distribution for its SpyroflexR range of consumer first aid dressings and has rights to acquire the associated trademark. The SpyroflexR brand name was acquired by Advanced Medical Solutions in 1999 and comprises a range of products for the treatment of cuts, grazes, minor bleeding wounds and blisters based on proprietary polyurethane membrane technology, it added. Under this new deal, AGS will now sell and distribute the range into both markets in the U.S., it said. Advanced Medical Solutions added it retains the patents for the products and will continue to develop and manufacture the complete product range. AGS will build the brand and has the right to acquire the SpyroflexR trademark for a total consideration of 450,000 stg subject to achieving minimum annual sales volumes. | |
|
21 FEB 2001
|
21/2/01 08:53 GMT Advanced Medical Solutions awarded 130 mln stg grant by universities LONDON (AFX) - Advanced Medical Solutions Group PLC said it has been awarded grants totalling 130 mln stg from the Universities of Aston and Glasgow, in support of the company's research on tissue engineering. It said the grants will be used to investigate cell-fibre interactions. Advanced Medical solutions will develop cell-fibre scaffolds for a project entitled "Nanobiotechnology and Medicine" in consortium with the University of Glasgow, financed under the European Framework V Scheme, it said. tw/rn | |
|
14 MAR 2001
|
Shares in Advanced Medical Solutions have jumped on news that the group has agreed a collaboration deal with Johnson & Johnson to supply a patented calcium alginate-based material for inclusion in some products for the US and Canadian consumer market. Don Evans, chief executive of AMS, said: "We are extremely pleased to be working with as strong a partner as Johnson & Johnson Consumer Products Company and this collaboration further enhances our position in the important American consumer products market. We are committed to launching innovative new products and this collaboration enables us to bring further enhanced value products into the market." |